METex14 lung cancer cell line models were established using CRISPR technology, where deletion of MET exon 14 in both alleles was regarded as mutated (METex14), and cell lines with intact MET exon 14 were used as wildtype (Figure 2A). This evidence concerns the gene MET and lung carcinoma.